The NexTGen team is supported through the Cancer Grand Challenges initiative. Learn more here
The NexTGen team is supported through the Cancer Grand Challenges initiative. Learn more here
Learn about updates and recent news
On 7th and 8th November 2023, the NexTGen team gathered at the Children’s National Hospital Research and Innovation Campus in Washington DC for their second annual research meeting. More than 80 NexTGen team members attended the event in person, with more joining...
Dr Christina Burke commented: The treatment options for rhabdomyosarcoma remain harsh, intensive and, in many cases, ineffective. With Alice’s Arc, we hope to translate the success of CAR T-cell immunotherapy to this childhood cancer. My goal is to understand how we...
This article entitled “Co-opting signaling molecules enables logic-gated control of CAR T cells” was published in March 2023.
On 7th and 8th November 2023, the NexTGen team gathered at the Children’s National Hospital Research and Innovation Campus in Washington DC for their second annual research meeting. More than 80 NexTGen team members attended the event in person, with more joining...
Dr Christina Burke commented: The treatment options for rhabdomyosarcoma remain harsh, intensive and, in many cases, ineffective. With Alice’s Arc, we hope to translate the success of CAR T-cell immunotherapy to this childhood cancer. My goal is to understand how we...
This article entitled “Co-opting signaling molecules enables logic-gated control of CAR T cells” was published in March 2023.
This article entitled “Co-opting signaling molecules enables logic-gated control of CAR T cells” was published in March 2023.
NexTGen scientists and advocates feature in this article relating to the changing face of the landscape of the childhood cancer sector.
Read about the members of the advocacy team and the role they play on NexTGen.
